• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生活方式干预改善唐氏综合征患儿代谢功能障碍相关脂肪性肝病

Lifestyle Intervention Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Children with Down Syndrome.

作者信息

Scoppola Vittorio, Crudele Annalisa, Mosca Antonella, Panera Nadia, Camillo Chiara di, Bock Caterina, Raponi Massimiliano, Villani Alberto, Alisi Anna, Valentini Diletta

机构信息

Research Unit of Genetics of Complex Phenotypes, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Hepatology and Liver Transplant Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

出版信息

Nutrients. 2025 Jul 16;17(14):2331. doi: 10.3390/nu17142331.

DOI:10.3390/nu17142331
PMID:40732956
Abstract

: We evaluated the efficacy of a good lifestyle intervention on the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in children with Down syndrome (DS). : This retrospective longitudinal study included 31 children with Down syndrome (DS) who were affected by MASLD and attended nutritional counseling based on a nutritional approach (e.g., Mediterranean diet and antioxidant supplements), as well as physical exercise. Clinical parameters, markers of low-grade systemic inflammation, and hepatic steatosis, as assessed by ultrasound, were evaluated at baseline (T0) and after 6 months (T1). : Several anthropometric and biochemical parameters, including body mass index, waist circumference, diastolic and systolic blood pressure, aspartate aminotransferase, basal insulin, insulin resistance, pro-inflammatory interleukin-1β, and anti-inflammatory interleukin-10, showed significant improvement after 6 months of a nutritional approach. This study also found a regression of at least one grade of hepatic steatosis in a significant portion of patients, especially in those who received antioxidant supplements. : Our study further supports the hypothesis that a healthy lifestyle intervention, based on adherence to the Mediterranean diet, natural supplements with antioxidant properties, and regular physical activity, can be considered a safe therapeutic approach for reducing the risk and severity of MASLD in children with DS.

摘要

我们评估了良好生活方式干预对唐氏综合征(DS)患儿代谢功能障碍相关脂肪性肝病(MASLD)严重程度的疗效。这项回顾性纵向研究纳入了31名患有MASLD的唐氏综合征患儿,他们接受了基于营养方法(如地中海饮食和抗氧化补充剂)以及体育锻炼的营养咨询。在基线(T0)和6个月后(T1)评估了临床参数、低度全身炎症标志物以及通过超声评估的肝脂肪变性。包括体重指数、腰围、舒张压和收缩压、天冬氨酸转氨酶、基础胰岛素、胰岛素抵抗、促炎白细胞介素-1β和抗炎白细胞介素-10在内的多项人体测量和生化参数在采用营养方法6个月后显示出显著改善。本研究还发现,相当一部分患者的肝脂肪变性至少有一个等级的消退,尤其是那些服用抗氧化补充剂的患者。我们的研究进一步支持了这样一种假设,即基于坚持地中海饮食、具有抗氧化特性的天然补充剂和定期体育活动的健康生活方式干预可被视为降低DS患儿MASLD风险和严重程度的一种安全治疗方法。

相似文献

1
Lifestyle Intervention Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Children with Down Syndrome.生活方式干预改善唐氏综合征患儿代谢功能障碍相关脂肪性肝病
Nutrients. 2025 Jul 16;17(14):2331. doi: 10.3390/nu17142331.
2
Aerobic-Resistance Training with Royal Jelly Supplementation Has a Synergistic Effect on Paraoxonase 1 Changes and Liver Function in Women with MASLD.补充蜂王浆的有氧抗阻训练对患有代谢功能障碍相关脂肪性肝病(MASLD)的女性的对氧磷酶1变化和肝功能具有协同作用。
Medicina (Kaunas). 2025 Feb 17;61(2):349. doi: 10.3390/medicina61020349.
3
Silymarin for adults with metabolic dysfunction-associated steatotic liver disease.水飞蓟素用于患有代谢功能障碍相关脂肪性肝病的成年人。
Cochrane Database Syst Rev. 2025 Jun 24;6(6):CD015524. doi: 10.1002/14651858.CD015524.pub2.
4
Dietary interventions for recurrent abdominal pain in childhood.儿童复发性腹痛的饮食干预措施
Cochrane Database Syst Rev. 2017 Mar 23;3(3):CD010972. doi: 10.1002/14651858.CD010972.pub2.
5
Dietary quality, perceived health, and psychological status as key risk factors for newly developed metabolic dysfunction-associated steatotic liver disease in a longitudinal study.一项纵向研究中,饮食质量、感知健康和心理状态作为新发生的代谢功能障碍相关脂肪性肝病的关键危险因素。
Nutrition. 2025 Feb;130:112604. doi: 10.1016/j.nut.2024.112604. Epub 2024 Oct 18.
6
Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort.遗传风险加剧了基于人群队列的肝脂肪变性、炎症和纤维化的饮食效应。
J Hepatol. 2024 Sep;81(3):379-388. doi: 10.1016/j.jhep.2024.03.045. Epub 2024 Apr 4.
7
Breaking boundaries: Unraveling metabolic dysfunction-associated steatotic liver disease in children of India and Canada.突破界限:解析印度和加拿大儿童中与代谢功能障碍相关的脂肪性肝病
Can Liver J. 2024 Feb 26;7(3):327-337. doi: 10.3138/canlivj-2023-0023. eCollection 2024 Aug.
8
Treadmill interventions with partial body weight support in children under six years of age at risk of neuromotor delay.对有神经运动发育迟缓风险的六岁以下儿童进行的带有部分体重支持的跑步机干预。
Cochrane Database Syst Rev. 2011 Dec 7(12):CD009242. doi: 10.1002/14651858.CD009242.pub2.
9
The Impact of Dietary Interventions on Metabolic Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Comorbid Conditions, Including Obesity and Type 2 Diabetes.饮食干预对代谢功能障碍相关脂肪性肝病(MASLD)及合并症(包括肥胖和2型糖尿病)代谢结局的影响
Nutrients. 2025 Apr 3;17(7):1257. doi: 10.3390/nu17071257.
10
Lifestyle modification programme for people living with HIV with metabolic dysfunction-associated steatotic liver disease: a randomised controlled trial.针对患有代谢功能障碍相关脂肪性肝病的HIV感染者的生活方式改变计划:一项随机对照试验。
Lancet HIV. 2025 Jun;12(6):e416-e427. doi: 10.1016/S2352-3018(25)00032-3. Epub 2025 May 8.

本文引用的文献

1
Evidence-based review of the nutritional treatment of obesity and metabolic dysfunction-associated steatotic liver disease in children and adolescents.儿童和青少年肥胖及代谢功能障碍相关脂肪性肝病营养治疗的循证综述
J Pediatr Gastroenterol Nutr. 2025 Sep;81(3):485-496. doi: 10.1002/jpn3.70099. Epub 2025 Jun 17.
2
AASLD Practice Statement on the evaluation and management of metabolic dysfunction-associated steatotic liver disease in children.美国肝病研究学会关于儿童代谢功能障碍相关脂肪性肝病评估与管理的实践声明。
Hepatology. 2025 Apr 29. doi: 10.1097/HEP.0000000000001368.
3
Hydroxytyrosol Ameliorates Colon Inflammation: Mechanistic Insights into Anti-Inflammatory Effects, Inhibition of the TLR4/NF-κB Signaling Pathway, Gut Microbiota Modulation, and Liver Protection.
羟基酪醇改善结肠炎症:对其抗炎作用、抑制TLR4/NF-κB信号通路、调节肠道微生物群及肝脏保护作用的机制性见解
Foods. 2025 Apr 4;14(7):1270. doi: 10.3390/foods14071270.
4
A Clinical Update on MASLD.非酒精性脂肪性肝病的临床进展
JAMA Intern Med. 2025 Jan 1;185(1):105-107. doi: 10.1001/jamainternmed.2024.6431.
5
A healthy lifestyle is prospectively associated with lower onset of metabolic dysfunction-associated steatotic liver disease.健康的生活方式与代谢功能障碍相关脂肪性肝病的发病风险降低呈前瞻性相关。
Hepatol Commun. 2024 Nov 4;8(11). doi: 10.1097/HC9.0000000000000583. eCollection 2024 Nov 1.
6
Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review.代谢功能障碍相关脂肪性肝病引起的抗氧化系统变化:综述
Arch Toxicol. 2025 Jan;99(1):1-22. doi: 10.1007/s00204-024-03889-x. Epub 2024 Oct 23.
7
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact.肠道微生物群和免疫细胞在代谢相关脂肪性肝病中的作用:临床影响。
Hepatol Int. 2024 Oct;18(Suppl 2):861-872. doi: 10.1007/s12072-024-10674-6. Epub 2024 Jul 12.
8
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).EASL-EASD-EASO 临床实践指南:代谢功能障碍相关脂肪性肝病(MASLD)的管理。
J Hepatol. 2024 Sep;81(3):492-542. doi: 10.1016/j.jhep.2024.04.031. Epub 2024 Jun 7.
9
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation.代谢功能障碍相关脂肪性肝病治疗的多面性:从地中海饮食到粪便微生物群移植
Medicina (Kaunas). 2024 Mar 29;60(4):563. doi: 10.3390/medicina60040563.
10
Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics?代谢相关脂肪性肝病(MASLD):儿科更合适治疗的新术语?
Pediatr Rep. 2024 Apr 10;16(2):288-299. doi: 10.3390/pediatric16020025.